Katharina Leonards
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.Dominic Schmid, Bettina Sobottka, Massimiliano Manzo
|Feb 24, 2022
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.Franziska C Adam, Jakub Szybinski, Jörg P Halter
|Sep 04, 2021
Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy.Sime Brkic, Simona Stivala, Alice Santopolo
|Jun 14, 2020
Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.Katharina Leonards, Marwa Almosailleakh, Samantha Tauchmann
|Sep 01, 2019
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.Ilaria Alborelli, Katharina Leonards, Sacha I Rothschild
Pageof 1
Frequent Collaborators
2 joint publications
Ilaria Alborelli
1 joint publications
Laura P Leuenberger
1 joint publications
Philip Jermann
1 joint publications
Marwa Almosailleakh
1 joint publications
Cécile Thirant
1 joint publications
Thomas Bock
1 joint publications
Matheus F Bezerra
1 joint publications
Alexandar Tzankov
1 joint publications
Robert Ivanek
1 joint publications
Juerg Schwaller